Cerebral dynamics of N-isopropyl-(123I)p-iodoamphetamine
Temporal changes in the distribution of N-isopropyl-(123I)p-iodoamphetamine (IMP) within the brain are measured with serial tomographic imaging. In the cerebellum there is a decrease in activity of 42% from the early (15-45 min postinjection (p.i.)) to the late (210-240 min p.i.) scan, while in the cortex the decrease is 18%, and in the basal ganglia there is no decrease within this time. In brain tumors there was no IMP uptake in the early as well as in the late scans, regardless of tumor type, perfusion rate, or blood-brain barrier dysfunction. In 11 of 43 patients with a cerebral infarction a real increase of 123I activity (mean +21%) was seen in the late images. This ''filling in'' phenomena might be useful in selecting patients for bypass surgery. In these patients the diaschisis cerebelli, seen in the early scans, disappeared in the late images. The regional distribution of IMP changes with time; spatial ratios might be blurred by temporal changes. High-flow areas such as visio-auditory centers can be delineated clearly after stimulation in fast early scans; in these areas the pharmacokinetics of 123I are different from other cortex regions. To get the full information from the IMP brain uptake, both spatial and temporal variation must be measured.
- Research Organization:
- Univ. School of Medicine, Hannover, Germany, F.R.
- OSTI ID:
- 5329933
- Journal Information:
- J. Nucl. Med.; (United States), Vol. 2
- Country of Publication:
- United States
- Language:
- English
Similar Records
Initial experience with SPECT (single-photon computerized tomography) of the brain using N-isopropyl I-123 p-iodoamphetamine: concise communication
Quantifying local cerebral blood flow by N-isopropyl-p-(123I)iodoamphetamine (IMP) tomography
Related Subjects
AMPHETAMINES
UPTAKE
CEREBELLUM
TOMOGRAPHY
IODINE 123
BRAIN
LABELLED COMPOUNDS
NERVOUS SYSTEM DISEASES
PATIENTS
TISSUE DISTRIBUTION
VASCULAR DISEASES
ANALEPTICS
AUTONOMIC NERVOUS SYSTEM AGENTS
BETA DECAY RADIOISOTOPES
BODY
CENTRAL NERVOUS SYSTEM
CENTRAL NERVOUS SYSTEM AGENTS
DIAGNOSTIC TECHNIQUES
DISEASES
DISTRIBUTION
DRUGS
ELECTRON CAPTURE RADIOISOTOPES
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
IODINE ISOTOPES
ISOTOPES
NERVOUS SYSTEM
NUCLEI
ODD-EVEN NUCLEI
ORGANS
RADIOISOTOPES
SYMPATHOMIMETICS
550601* - Medicine- Unsealed Radionuclides in Diagnostics